Pancreatic Polypeptide vs Uroguanylin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Pancreatic polypeptide (PP) is a 36-amino acid member of the NPY/PYY peptide family secreted by PP cells (F cells) in the pancreatic islets and periphery of islets of Langerhans. Released in a biphasic response to meal ingestion (cephalic phase via vagal activation, then nutrient...
Calculate Pancreatic Polypeptide dose →Uroguanylin is a 16-amino acid peptide hormone secreted by enterochromaffin cells of the proximal small intestine in response to meal-induced luminal signals. It activates guanylyl cyclase C (GC-C) receptors both locally in intestinal epithelium and, at supraphysiological concent...
Calculate Uroguanylin dose →| Parameter | Pancreatic Polypeptide | Uroguanylin |
|---|---|---|
| Category | GI Hormone / Satiety | GI Hormone / Satiety |
| Research | Research / Endogenous Hormone | Research / Endogenous Hormone |
| Half-Life | 6-7 minutes (plasma) | 5-15 minutes (plasma); rapidly degraded |
| Typical Dose | Research: 0.5-2 pmol/kg/min IV infusion | Research: 100 pmol/kg IV; ICV for CNS satiety studies |
| Frequency | Endogenous: meal-entrained pulses; research: single infusion | Endogenous: meal-entrained; research per session |
| Route | Endogenous (pancreatic PP cells); research IV | Endogenous (proximal small intestine enterocytes); research IV |
| FDA Status | Not approved as drug | Not approved (uroguanylin itself); analogs plecanatide/linaclotide FDA approved for constipation |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.